Skip to main content
. 2021 Mar 10;21:254. doi: 10.1186/s12879-021-05947-6

Table 2.

Drugs used in treatment regimen (n = 49)

Drug Patients, n (%)
Amikacin 49 (100)
Ethambutol 29 (59.2)
Pyrazinamide 29 (59.2)
Rifabutin 3 (6.1)
Levofloxacin 7 (14.3)
Moxifloxacin 44 (89.8)
Clofazimine 44 (89.8)
Linezolid 26 (53.1)
Ethionamide 30 (61.2)
Cycloserine 30 (61.2)
Para-aminosalicylic acid 32 (65.3)
Imipenem 12 (24.5)
Amoxicillin-clavulanate 6 (12.2)
Bedaquiline 5 (10.2)
Delamanid 1 (2)